14/04/2026
Interesting read: a possible cause of chronic lower back pain without definite findings on imaging may be link to your gut microbiome
https://www.facebook.com/share/p/1RAQ9YMJuC/
๐ฃ๐ฎ๐๐ถ๐ฒ๐ป๐๐ ๐ช๐ถ๐๐ต ๐๐ต๐ฟ๐ผ๐ป๐ถ๐ฐ ๐๐ผ๐ ๐๐ฎ๐ฐ๐ธ ๐ฃ๐ฎ๐ถ๐ป ๐ช๐ถ๐๐ต๐ผ๐๐ ๐๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ฑ ๐๐ถ๐๐ธ ๐๐ฒ๐ด๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐๐
๐ต๐ถ๐ฏ๐ถ๐ ๐๐๐ ๐ ๐ถ๐ฐ๐ฟ๐ผ๐ฏ๐ถ๐ผ๐บ๐ฒ ๐๐๐๐ฏ๐ถ๐ผ๐๐ถ๐
As physical therapist and clinical exercise physiologists, we are constantly looking for the "why" behind those persistent cases where a patientโs MRI doesn't match their level of pain and disability.
๐ A brand-new study by Sima et al. (2026, https://onlinelibrary.wiley.com/doi/10.1002/jsp2.70174) offers a compelling look at the "gut-disk axis" as a potential driver for chronic low back pain (LBP). Historically, weโve relied on imaging to find structural culprits, but as Sima and Diwan (2025, https://pubmed.ncbi.nlm.nih.gov/39867670/) point out, many patients lack an easily identifiable surgical pathology. This research bridges that gap by investigating how our internal ecosystem might be fueling spinal inflammation from the inside out.
๐ง๐ต๐ฒ ๐ฆ๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐๐๐-๐๐ถ๐๐ธ ๐๐
๐ถ๐
The study compared 28 chronic LBP patients without advanced disk degeneration to 28 healthy, matched controls. The researchers built upon the work of Li et al. (2022, https://pubmed.ncbi.nlm.nih.gov/35286474/), who first proposed the "gut-disk axis"โa pathway where intestinal dysbiosis leads to systemic inflammation that eventually sensitizes the nerves around our spinal disks. This theory is supported by earlier findings from Shmagel et al. (2019), who found a significant association between dysbiosis and the presence and severity of musculoskeletal pain, particularly in the lower back.
๐ What Sima et al. (2026) discovered was a significant drop in alpha diversity (the richness of the microbiome) in LBP patients. This is a hallmark of dysbiosis also noted by Nitert et al. (2020, https://pmc.ncbi.nlm.nih.gov/articles/PMC7492308/) in overweight back pain cohorts. Specifically, the LBP group showed a depletion of Bacteroidota and Parabacteroides. These "good" bacteria produce short-chain fatty acids (SCFAs), which Agus et al. (2021, https://pubmed.ncbi.nlm.nih.gov/33272977/) and Ney et al. (2023, https://pubmed.ncbi.nlm.nih.gov/36977462/) have shown are vital for maintaining the gut barrier and suppressing pro-inflammatory cytokines like IL-17.
๐ช๐ต๐ ๐๐ ๐ ๐ฎ๐๐๐ฒ๐ฟ๐ ๐ณ๐ผ๐ฟ ๐ข๐๐ฟ ๐ฃ๐ฎ๐๐ถ๐ฒ๐ป๐๐?
When these protective bacteria are lost, "bad" players like Proteobacteria and Desulfobacterota take over. This shift increases intestinal permeability allowing endotoxins to enter the bloodstream. Once these toxins reach the intervertebral disk, they can trigger the infiltration of nociceptive fibers. This process, supported by research from Larsen (2017, https://pubmed.ncbi.nlm.nih.gov/28542929/) on Prevotella-induced inflammation and Cheng et al. (2013, https://pubmed.ncbi.nlm.nih.gov/23680281/) on Th17 cell frequency, might explain the pathogenesis and pain severity of IVD degeneration in part.
๐ก Ultimately, this suggests that our role in the clinic might extend beyond biomechanics. Emerging evidence hints that therapies we already use, like exercise and psychologically informed practice, might actually help by enhancing microbial diversity. This study reinforces that we need a holistic, biopsychosocial approach to back pain that considers systemic inflammation and perhaps even microbiome-targeted interventions to get our patients moving better.